Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, SHL Telemedicine's Enterprise Value is CHF29.05 Mil.
SHL Telemedicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-10.83 Mil. Therefore, SHL Telemedicine's EV-to-EBIT ratio for today is -2.68.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, SHL Telemedicine's Enterprise Value is CHF29.05 Mil.
SHL Telemedicine's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-4.81 Mil. Therefore, SHL Telemedicine's EV-to-EBITDA ratio for today is -6.05.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, SHL Telemedicine's Enterprise Value is CHF29.05 Mil.
SHL Telemedicine's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was CHF47.23 Mil. Therefore, SHL Telemedicine's EV-to-Revenue ratio for today is 0.62.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, SHL Telemedicine's Enterprise Value is CHF29.05 Mil.
SHL Telemedicine's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-3.94 Mil. Therefore, SHL Telemedicine's EV-to-FCF ratio for today is -7.37.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
SHL Telemedicine (XSWX:SHLTN) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
SHL Telemedicine's current Enterprise Value is CHF29.05 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-10.83 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
SHL Telemedicine's current Enterprise Value is CHF29.05 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-4.81 Mil.
SHL Telemedicine's current Enterprise Value is CHF29.05 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was CHF47.23 Mil.
SHL Telemedicine's current Enterprise Value is CHF29.05 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-1.49 Mil.
SHL Telemedicine's current Enterprise Value is CHF29.05 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-3.94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHL Telemedicine Enterprise Value Related Terms
SHL Telemedicine Enterprise Value Historical Data
* Premium members only.
The historical data trend for SHL Telemedicine's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SHLTN vs VEEV, BTSG, TEM: Enterprise Value Comparison
For the Health Information Services subindustry, SHL Telemedicine's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SHL Telemedicine Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Enterprise Value distribution charts can be found below:
* The bar in red indicates where SHL Telemedicine's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
SHL Telemedicine's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of CHF29.05 Mil mean?
SHL Telemedicine (XSWX:SHLTN) has a Enterprise Value of CHF29.05 Mil as of Jul. 04, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on SHL Telemedicine and its competitors.
Is SHL Telemedicine's Enterprise Value too high?
SHL Telemedicine's current Enterprise Value is CHF29.05 Mil. Overall, SHL Telemedicine has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Enterprise Value compare to VEEV and BTSG?
SHL Telemedicine's Enterprise Value of CHF29.05 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on SHL Telemedicine and its competitors. SHL Telemedicine's current Enterprise Value is CHF29.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
Based on GuruFocus' analysis, SHL Telemedicine (XSWX:SHLTN) is currently considered Possible Value Trap. The stock's GF Value™ is CHF2.62, compared to a current price of CHF1.05 — trading 59.9% below its estimated fair value. The current Enterprise Value is CHF29.05 Mil. SHL Telemedicine's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For SHL Telemedicine (XSWX:SHLTN), the current Enterprise Value is CHF29.05 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SHL Telemedicine (XSWX:SHLTN) Overvalued in 2026?
Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued.
The current stock price of CHF1.05 is trading 59.9% below its estimated GF Value™ of CHF2.62.
GuruFocus considers SHL Telemedicine to be Possible Value Trap.
Key valuation signals for XSWX:SHLTN:
Enterprise Value: CHF29.05 Mil
GF Value™: CHF2.62 vs. price of CHF1.05 (59.9% below fair value)
No single metric tells the full story. See the XSWX:SHLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
52GF Score
Get the complete analysis for XSWX:SHLTN
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SHLTN has been successfully added to your 
